A California cardiologist cannot understand why COVID-19 blood clot issues get more media attention than the more prevalent condition, myocarditis.
“The blood clot issue with Johnson & Johnson may be in the hundreds, but the heart issue is in the thousands,” explained Doctor Sanjay Verma. “It’s a different level of patient exposure.”
Dr. Verma said his Coachella Valley practice sees a few hundred patients each month. Since last summer, he identified “possibly one dozen” patients whose heart conditions might be connected to the COVID vaccines, according to a report in The Epoch Times. “I can only say possibly—not definitively—because we do not yet have any diagnostic test that 100 percent says ‘this caused this.’ What we do is what’s called a process of exclusion.”
The cardiologist said it is not just news reports that elevate concerns over coronavirus clots from vaccines. “It’s to the extent that they’ve basically put a caution to only use the Johnson and Johnson if there’s no other choice,” Verma said. “So that’s a pretty strong caution. Whereas for the mRNA vaccines and heart issues, the warning is there on the FDA factsheet. But the number of people affected is far greater.”
He contests conclusions reached by a study published by the New England Journal of Medicine in October indicating greater risk of myocarditis from contracting COVID-19 than from vaccination.
The study was flawed, Verma concluded, after conducting his own independent research.
The California doctor explained that the NEJM study combined patients from all age groups in its analysis. He noted COVID-19 hospitalizations are predominantly for patients older than 65. Approximately 91 percent of all COVID-19 hospitalizations were for people with underlying medical conditions, according to the Centers for Disease Control and Prevention. The CDC Director Rochelle Walensky has stated that 75 percent of coronavirus deaths were in people with at least four underlying medical conditions. Verma cited that as evidence the myocarditis cases after COVID infection likely occur in older people with underlying medical conditions.
He said a 2020 study published in the medical journal Nature demonstrated the myocarditis risks for patients under 40 is far greater after COVID-19 vaccine than it is for people who become infected with COVID.
Scroll down to leave a comment and share your thoughts.